The outlook of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key markets has introduced considerable uncertainty . Investors are now facing the effect of generic competition , diminis